240 related articles for article (PubMed ID: 11290602)
1. Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat-driven transcription and a possible implication of SHP-1.
Fortin JF; Barbeau B; Robichaud GA; Paré ME; Lemieux AM; Tremblay MJ
Blood; 2001 Apr; 97(8):2390-400. PubMed ID: 11290602
[TBL] [Abstract][Full Text] [Related]
2. Treatment of human T cells with bisperoxovanadium phosphotyrosyl phosphatase inhibitors leads to activation of cyclooxygenase-2 gene.
Barat C; Tremblay MJ
J Biol Chem; 2003 Feb; 278(9):6992-7000. PubMed ID: 12493747
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of the NFAT1 factor by CD45: implication in HIV-1 long terminal repeat activation.
Barbeau B; Robichaud GA; Fortin JF; Tremblay MJ
J Immunol; 2001 Sep; 167(5):2700-13. PubMed ID: 11509614
[TBL] [Abstract][Full Text] [Related]
4. p56(lck), ZAP-70, SLP-76, and calcium-regulated effectors are involved in NF-kappaB activation by bisperoxovanadium phosphotyrosyl phosphatase inhibitors in human T cells.
Ouellet M; Barbeau B; Tremblay MJ
J Biol Chem; 1999 Dec; 274(49):35029-36. PubMed ID: 10574981
[TBL] [Abstract][Full Text] [Related]
5. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
Tsatsanis C; Patriotis C; Tsichlis PN
Oncogene; 1998 Nov; 17(20):2609-18. PubMed ID: 9840924
[TBL] [Abstract][Full Text] [Related]
6. Activation of HTLV-I gene transcription by protein tyrosine phosphatase inhibitors.
Langlois M; Audet B; Legault E; Paré ME; Ouellet M; Roy J; Dumais N; Mesnard JM; Rothstein DM; Marriott SJ; Tremblay MJ; Barbeau B
Virology; 2004 Nov; 329(2):395-411. PubMed ID: 15518818
[TBL] [Abstract][Full Text] [Related]
7. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
[TBL] [Abstract][Full Text] [Related]
8. Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kappaB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds.
Barbeau B; Bernier R; Dumais N; Briand G; Olivier M; Faure R; Posner BI; Tremblay M
J Biol Chem; 1997 May; 272(20):12968-77. PubMed ID: 9148903
[TBL] [Abstract][Full Text] [Related]
9. Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation.
Su MW; Yu CL; Burakoff SJ; Jin YJ
J Immunol; 2001 Mar; 166(6):3975-82. PubMed ID: 11238643
[TBL] [Abstract][Full Text] [Related]
10. NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells.
Cron RQ; Bartz SR; Clausell A; Bort SJ; Klebanoff SJ; Lewis DB
Clin Immunol; 2000 Mar; 94(3):179-91. PubMed ID: 10692237
[TBL] [Abstract][Full Text] [Related]
11. T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-kappaB and NFAT with its enhancer region.
Lemieux AM; Paré ME; Audet B; Legault E; Lefort S; Boucher N; Landry S; van Opijnen T; Berkhout B; Naghavi MH; Tremblay MJ; Barbeau B
J Biol Chem; 2004 Dec; 279(51):52949-60. PubMed ID: 15466412
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-kappaB and NFAT.
Navarro J; Punzón C; Jiménez JL; Fernández-Cruz E; Pizarro A; Fresno M; Muñoz-Fernández MA
J Virol; 1998 Jun; 72(6):4712-20. PubMed ID: 9573235
[TBL] [Abstract][Full Text] [Related]
13. Grb3-3 is up-regulated in HIV-1-infected T-cells and can potentiate cell activation through NFATc.
Li X; Multon MC; Henin Y; Schweighoffer F; Venot C; Josef J; Zhou C; LaVecchio J; Stuckert P; Raab M; Mhashilkar A; Tocque B; Marasco WA
J Biol Chem; 2000 Oct; 275(40):30925-33. PubMed ID: 10906142
[TBL] [Abstract][Full Text] [Related]
14. HIV-1, NFAT, and cyclosporin: immunosuppression for the immunosuppressed?
Cron RQ
DNA Cell Biol; 2001 Dec; 20(12):761-7. PubMed ID: 11879569
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of antigen-receptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck).
Newman DK; Hamilton C; Newman PJ
Blood; 2001 Apr; 97(8):2351-7. PubMed ID: 11290597
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor of activated T cells is a driving force for preferential productive HIV-1 infection of CD45RO-expressing CD4+ T cells.
Robichaud GA; Barbeau B; Fortin JF; Rothstein DM; Tremblay MJ
J Biol Chem; 2002 Jun; 277(26):23733-41. PubMed ID: 11956207
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the nuclear factor of activated T cells in stably transfected Jurkat cell clones.
Li W; Handschumacher RE
Biochem Biophys Res Commun; 1996 Feb; 219(1):96-9. PubMed ID: 8619834
[TBL] [Abstract][Full Text] [Related]
18. Uncoupling activation-dependent HS1 phosphorylation from nuclear factor of activated T cells transcriptional activation in Jurkat T cells: differential signaling through CD3 and the costimulatory receptors CD2 and CD28.
Hutchcroft JE; Slavik JM; Lin H; Watanabe T; Bierer BE
J Immunol; 1998 Nov; 161(9):4506-12. PubMed ID: 9794375
[TBL] [Abstract][Full Text] [Related]
19. Rosmarinic acid inhibits Ca2+-dependent pathways of T-cell antigen receptor-mediated signaling by inhibiting the PLC-gamma 1 and Itk activity.
Kang MA; Yun SY; Won J
Blood; 2003 May; 101(9):3534-42. PubMed ID: 12511421
[TBL] [Abstract][Full Text] [Related]
20. Attachment of human immunodeficiency virus-1 (HIV-1) particles bearing host-encoded B7-2 proteins leads to nuclear factor-kappa B- and nuclear factor of activated T cells-dependent activation of HIV-1 long terminal repeat transcription.
Bounou S; Dumais N; Tremblay MJ
J Biol Chem; 2001 Mar; 276(9):6359-69. PubMed ID: 11096063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
